FIRST EVIDENCE FOR THE TRANSLATIONAL POTENTIAL OF MESENCURET, A PROFESSIONALIZED ALLOGENEIC MESENCHYMAL CELL THERAPY, FOR TREATING IMMUNOTHERAPY-RELATED CYTOKINE RELEASE SYNDROME-MedSci.cn - 梅斯（MedSci）

FIRST EVIDENCE FOR THE TRANSLATIONAL POTENTIAL OF MESENCURET, A PROFESSIONALIZED ALLOGENEIC MESENCHYMAL CELL THERAPY, FOR TREATING IMMUNOTHERAPY-RELATED CYTOKINE RELEASE SYNDROME

Kushnir, O; Novak, A; Ben David, D; Barzilai, MG; Kaneti, L; Meretzki, S; Bronshtein, T

CYTOTHERAPY, 2022; 24 (5): S24

科室
- - 订阅+
  - 更多科室
工具
服务